Curcumin Eye Supplement Composition for Macular Pigment Support
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing eye health supplements do not effectively support macular pigment density, visual processing speed, and recovery from glare, particularly in older individuals, and may not provide sufficient amounts of key nutrients like zeaxanthin and lutein for optimal eye health benefits.
Innovation Solution
A dosage form comprising zeaxanthin, lutein, vitamin E, zinc, curcumin, and omega-3 oils, specifically designed to provide higher amounts of DHA and EPA, which are formulated into a softgel for easy administration, supporting a healthy retina and visual performance by enhancing macular pigment density and improving visual recovery from glare.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If existing eye health supplement formulations are used, then basic nutritional support is provided, but sufficient amounts of key nutrients like zeaxanthin and lutein are not provided for optimal eye health benefits
Solution Approach 1:
The patent changes the concentration parameters of key nutrients, specifically providing 1-10 mg zeaxanthin and 10-40 mg lutein per dosage form, which are higher amounts than many existing formulations. This parameter change directly addresses the contradiction by increasing the quantity of substances to achieve reliable eye health benefits
Solution Approach 2:
The patent creates a composite supplement formulation containing multiple nutrients in specific ratios: zeaxanthin, lutein, omega-3 oils (DHA and EPA), vitamin E, and zinc. This composite approach ensures that all key nutrients are provided together in synergistic combinations, resolving the contradiction between providing sufficient quantities and achieving reliable effectiveness
2Reliability
If higher amounts of DHA and EPA are provided, then visual processing speed and glare recovery are enhanced, but the complexity of the formulation increases
Solution Approach 1:
The patent uses omega-3 oils (DHA and EPA) that serve multiple functions: supporting visual processing speed, enhancing glare recovery, and contributing to overall retinal health. This multi-functionality allows higher amounts to be provided without proportionally increasing formulation complexity, as a single ingredient class addresses multiple performance requirements
Solution Approach 2:
The patent combines DHA and EPA in a specific ratio (3:2 or 4:1) within a single omega-3 oil component, merging two essential fatty acids into one integrated formulation element. This combining approach provides the benefits of both nutrients while managing formulation complexity through a unified delivery system
3Reliability
If a comprehensive nutrient profile is provided, then superior eye health benefits are achieved, but the dosage form becomes more complex
Solution Approach 1:
The patent optimizes the dosage parameters of each nutrient to achieve comprehensive benefits while managing complexity. Specific ranges are provided: 1-10 mg zeaxanthin, 10-40 mg lutein, 250-1000 mg omega-3 oils, 15-50 mg vitamin E, and 5-20 mg zinc. These parameter specifications create a balanced formulation that delivers superior eye health benefits without unnecessary complexity
Solution Approach 2:
The patent applies local quality by providing nutrients in eye-specific concentrations that match retinal requirements. The formulation is tailored with higher concentrations of carotenoids (zeaxanthin and lutein) specifically for macular pigment support, and appropriate amounts of omega-3s for photoreceptor health, rather than using uniform distribution of all nutrients
Data Source
AI summary
An eye health supplement and methods of using the eye health supplement are disclosed.